Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of Mast Cell Precursors

Completed

Conditions: Mastocytosis
Healthy Volunteer

First Posted Date: 1999-11-04

Last Posted Date: 2022-11-07

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 202

Registration Number: NCT00001756

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals

Completed

Conditions: Atopic Dermatitis
Healthy
Mastocytosis

First Posted Date: 1999-11-04

Last Posted Date: 2007-12-13

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 40

Registration Number: NCT00001760

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Study of Patients With Strongyloides Stercoralis Infection

Completed

Conditions: HIV Infection
Nematode Infection
Strongyloidiasis

First Posted Date: 1999-11-04

Last Posted Date: 2009-08-25

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 650

Registration Number: NCT00001245

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Drug Interactions Among Anti-HIV Agents

Phase 1

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 22

Registration Number: NCT00001766

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients

Phase 2

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 36

Registration Number: NCT00001474

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous Disease

Phase 1

Completed

Conditions: Chronic Granulomatous Disease

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00001765

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients

Phase 2

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 80

Registration Number: NCT00001357

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz

Phase 2

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 25

Registration Number: NCT00001758

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

A Phase I/II Study of the Combination of Azidothymidine and Interleukin-2 (IL-2) in the Treatment of HIV-Infected Patients

Phase 2

Completed

Conditions: HIV Infection

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 73

Registration Number: NCT00001282

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Etanercept to Treat Wegener's Granulomatosis

Phase 2

Completed

Conditions: Vasculitis
Wegener's Granulomatosis

First Posted Date: 1999-11-04

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 60

Registration Number: NCT00001901

Locations: 🇺🇸
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy